Trump Meets CEOs Of Drug Companies Heavily Funded By Feds

By Ariel Cohen / April 7, 2020 at 10:06 AM
Updated Story President Donald Trump spoke by phone to heads of pharmaceutical and biotech companies on Monday afternoon (April 6) about the status of research on COVID-19 drugs. Some of the executives lead companies that recently received significant funding from the federal government to develop COVID-19 drugs. Participants included Amgen CEO Robert Bradway, Genentech CEO Alexander Hardy, Gilead CEO Daniel O’Day and Regeneron CEO Leonard Schliefer. The White House said the drug makers and Trump discussed the...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.